DRKS00010594
Completed
Phase 4
Interindividual Comparison Trial – Two intraocular lenses with extended depth of focus - IC8 vs. Symfony
niversitätsklinikum Knappschaftskrankenhaus Bochum GmbH Augenklinik0 sites43 target enrollmentJuly 18, 2016
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Cataract
- Sponsor
- niversitätsklinikum Knappschaftskrankenhaus Bochum GmbH Augenklinik
- Enrollment
- 43
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Visual acuity reducing cataract (LOCS III Grading, 1\-5\)
- •\- Visual acuity \<\= 0,63 dec
- •\- Age \>22 year
- •\- planned Cataract surgery for both eyes
- •\- potential visual acuity after surgery \>\= 0,8 dec.
- •\- clear ocular media, except cataract
- •\- voluntary participation in the study
- •\- understood and signed informed consent
Exclusion Criteria
- •\- IOL power outside the range of \+20\.0 D to \+27,0 D
- •\- Dilated pupil size of less than 6\.0 mm
- •\- Pupillary abnormalities
- •\- microphthalmos
- •\- Prior corneal surgery or intraocular surgery
- •\- Astigmatism\> 0\.75 diopters, irregular astigmatism
- •\- corneal abnormalities or degenerative disease to reduce the visual acuity during the study to 0\.63 or lower
- •\- Active inflammation, diseases, pathologies or infection of the anterior or posterior segment of the eye
- •\- Glaucoma or ocular hypertension uncontrolled
- •\- Congenital cataracts
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
observational comparative study: Intravitreal treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) with a bispecific antibody Vabysmo® (faricimab) vs. a classical anti-VEGF inhibitor Eylea® (aflibercept) in a treat-and-extend-regimen (FATE).H35.30H36.0Diabetic retinopathyDRKS00031548Augenklinik der Medizinischen Hochschule Hannover136
Recruiting
Not Applicable
Performance comparison among different intraocular lenses in cataract surgeryCataractJPRN-UMIN000035630Saneikai Tsukazaki Hospital5,000
Completed
Phase 3
Comparison, effect of Ophthalmic ointment tetracycline1% and erythromycin 0.5% in prophylaxis of ophthalmia Neonatorum.Condition 1: neonatal conjunctivitis. Condition 2: Gonococcal conjunctivitis.Neonatal conjunctivitisGonococcal infection of eyeIRCT201101295714N1niversity of Medical Sciences Vice chancellor for research, Kordistan330
Recruiting
Not Applicable
To test the cosmetic safety by assessing the eye irritation and also to assess the no eye tears in healthy male and female human volunteers.CTRI/2022/01/039626Vishal Mega Mart Pvt Ltd
Completed
Not Applicable
Evaluation of treatment options of central serous chorioretinopathyCentral Serous Chorioretinoathy.Central Serous ChorioretinopathyIRCT2017041533448N1Vice chancellor for research, Zahedan University of Medical Sciences30